General
2 min read
Nestlé Targets GLP-1 Drug Users with AI-Driven Nutritional Products, Expands Asia Offerings
Nestlé is transforming the rise of GLP-1 weight-loss medications into a commercial opportunity by developing specialised products for consumers taking drugs like Ozempic and Wegovy. The company is using artificial intelligence and nutritional science to…